Efficacy of Getong Tongluo Capsule(葛酮通络胶嚢)for Convalescent-Phase of Ischemic Stroke and Primary Hypertension:A Multicenter,Randomized,Double-Blind,Controlled Trial

Objective:To evaluate whether the efficacy of Getong Tongluo Capsule(葛酮通络胶囊,GTC,consisted of total flavone of Radix Puerariae)on improving patients'quality of life and lowering blood pressure are superior to the extract of Ginkgo biloba(EGB)for patients with convalescent-phase ischemic stroke and primary hypertension.Methods:This randomized,positive-drug-and placebo-controlled,double-blind trial was conducted from September 2015 to October 2017.Totally 477 eligible patients from 18 hospitals in China were randomly assigned in a 2:1:1 ratio to the following interventions,twice a day for 12 weeks:(1)GTC 250 mg plus EGB-matching placebo 40 mg(237 cases,GTC group),(2)EGB 40 mg plus GTC-matching placebo 250 mg(120 cases,EGB group)or(3)GTC-matching placebo 250 mg plus EGB-matching placebo 40 mg(120 cases,placebo group).Moreover,all patients were orally administered aspirin enteric-coated tablets 100 mg,once a day fo r 12 weeks.The primary outcome was the Barthel Index(Bl).The secondary outcomes included the control rate of blood pressure and National Institutes of Health Stroke Scale(NIHSS)scores.The incidence and severity of adverse events(AEs)were calculated and assessed.Results:The Bl relative independence rates,the clinical recovery rates of NIHSS,and the total effective rates of NIHSS in the GTC and EGB groups were significantly higher than the placebo group at 12 weeks after treatment(P<0.05),and no statistical significance was found between the GTC and EGB groups(P>0.05).The control rate of blood pressure in the GTC group was significantly higher than the EGB and placebo groups at 12,18 and 24 weeks after treatment(P<0.01).There were no statistically significant differences in the incidences of AEs,adverse drug reactions,or serious AEs among the 3 groups(P>0.05).Conclusion:GTC exhibited significant efficacy in improving patients'quality of life as well as neurological function and controlling hypertension.     

抗震救灾中的传染病防治工作原则

人类的历史教训证明,包括大地震在内的严重自然灾害,对地域生态环境和人类居住条件造成极大的破坏,对灾区人员的健康造成沉重的打击.在这种情况下,发生重大传染病流行的风险将会显著增加.汶川大地震发生后,搜寻生还者,抢救伤病员是抗震救灾第一阶段的重点.     

A Bibliometrics Analysis on Academic Influence of Chinese Journal of Integrated Traditional and Western Medicine

Objective:To illustrate the academic influence of Chinese Journal of Integrated Traditional and Western medicine,and provide suggestions for further development of the Journal.Methods:Taking the China National Knowledge Infrastructure(CNKI)database as main source and the Chinese Science Citation Database(CSCD)as reference,the researchers retrieved the related data of the Journal such as its publication quantity,citations,fund projects,authors,institutions and regions from 1981 to 2018,analyzed these data by means of bibliometrics and information visualization with EXCEL,SPSS,VISIO,MATLAB and other softwares.Results:Through the analysis of the main indicators,the relevant indicators of the Journal’s academic influence revealed the developing trend of the Journal.Cardiovascular and cerebrovascular diseases,endocrine,digestive system,pharmacological research of Chinese medicine and gynecology,as the hot topics in the discipline and academic,were clarified.Conclusions:All indicators show that the Journal is a high-quality journal reflecting the excellent achievements in the field of integrated Chinese and Western medicine in China.Through further analysis of relevant indicators,the authors put forward some specific suggestions on how to run the Journal well.     

考试制度管理与改革之我见

分析目前考试制度存在的主要问题有命题、复习题、补考制度等方面的弊端,提出考试制度的改革要在加强"三风"建设、做好试题的编审工作、建立完善的考试管理制度、严肃补考纪律等方面下工夫,让严肃的考风带动良好的学风,从而提高教学质量.     

Vogt-小柳-原田综合征误诊1例报告

1临床资料 患者,男,29岁.入院前10d双眼视力突然下降,伴轻微头痛,曾就诊于其他医院,经眼科常规检查及眼部B超检查,诊断为原发性视网膜脱离,用药不详,因治疗效果不佳,于2002年10月18日来本院就诊.入院时自诉头痛明显,全身状况不佳,视力:右眼指数/1 m,左眼指数/1 m,双眼轻度睫状充血,角膜后可见细小点状沉着物,房水闪辉阳性,瞳孔呈药物性散大,直径5.5 mm,晶体不混浊,玻璃体可见条状混浊,眼压正常.     

婴幼儿游泳探讨

游泳是人类生活中最自然的生理活动和本能之一。不仅人类，哺乳动物也常有游泳行为，是生活中自然形成和掌握的一种本能。我们认为人和动物一样，生来就具有适应环境的能力。很多动物，无论大小都有游泳本领，不用谁来教，在水中通过多种姿势和划水方法，他们都会把鼻子露出水面，往岸上游。可是人类这种本能后来泯灭了。我们认为社会就是大海，人生就如在大海中游泳，从小让孩子在水中学会挣扎，锻炼拼搏精神，促进胎儿到婴幼儿神经及各脏器的持续发育，使生长的过程得到进一步、更高质量的发展，这对他们一生的好处都是不可估量的。     

头孢氨苄胶囊致过敏反应1例

1 临床资料 患者,男,66岁.因受凉后出现咳嗽、咯痰2d,其家属给予头孢氨苄胶囊0.5g口服后约10min后患者出现胸闷、心慌、呼吸困难、口唇紫绀,继而出现心悸出汗、全身无力、意识丧失、血压下降(60/30mmHg).医护人员迅速到达现场急救,立即给予吸氧、肌注肾上腺素1mg,静注地塞米松10mg,异丙嗪25mg,用药10min后病情好转,测血压80/60mmHg,1h后恢复正常.     

中国医药生物技术协会纳米生物技术分会批准成立大会在深圳召开

2007年12月31日,中国医药生物技术协会纳米生物技术分会批准成立大会在深圳市召开来自全国纳米生物技术领域的近百所大学、中科院研究所、医院、药厂、公司的院士、教授、主任医师、工程技术人员、企业主管出席了成立大会.会议由中国科学院姚开泰院士、中国工程院何继善院士、上海交通大学彭志海教授主持.复旦大学、北京大学、中南大学、清华大学、上海交通大学、四川大学、中山大学、浙江大学、中科院理化所、解放军总医院、石药集团、纳米生物技术公司等单位作了重要发言.     

国际心肺移植新进展——2006年第26届国际心肺移植协会年会报道

2006年4月5日至4月8日第26届国际心肺移植协会(ISHLT)年会在西班牙马德里隆重召开,来自全世界从事心肺移植的专家,包括心外科、胸外科、心内科、呼吸科、麻醉科、ICU、病理科、供体协调等从事基础及临床研究等相关科室的专家共2 000多人参加了此次盛会.     

东方大峡谷的民族医药之花——云南傈僳族医药简介

傈僳族是我国民族大家族中一个人数不多但却古老的成员.主要聚居在云南省怒江傈僳族自治州,在丽江和迪族、大理、保山、德宏、临沧等州县,以及四川省的盐源、盐边等县也有分布.根据2000年第5次全国人口普查统计,傈傈族人口数为634912.     

山东省急性淋巴细胞白血病患儿HLA-A、B、DRB1等位基因多态性研究

目的:研究山东省汉族急性淋巴细胞性白血病(ALL)患儿与等位基因HLA-A、B、DRB1的多态性的遗传关联。方法:采用聚合酶链反应-序列特异性寡核苷酸探针(PCR-SSO)方法,对197例ALL患儿和5841例健康脐带血样本等位基因HLA-A、B、DRB1多态性进行研究。结果:在等位基因HLA-A、B、DRB1中,ALL患儿的A11和A24;B40、B15、B56、B67和B27;DR9、DR12、DR14和DR16等基因的基因频率显著高于正常人群(P<0.01)。而HLA-B48、DR7和DR15等基因的基因频率显著下降(P<0.05)。结论:基因HLA-A11、A24、B40、B15、B56、B67、B27、DR9、DR12、DR14、DR16对ALL患儿有遗传易感作用,尤其是B40与ALL具有强相关性;而基因HLA-B48、DR7、DR15等对ALL患儿有遗传拮抗作用。     

肝素抗凝血浆在临床化学检测中的应用

目的探讨肝素在不同抗凝浓度下对临床化学检测指标的影响。方法模拟临床工作中出现的4种肝素浓度抗凝血浆与血清标本在相同条件下配对检测27项临床化学指标。结果肝素不同抗凝浓度血浆与血清比较:总蛋白(TP)、白蛋白(ALB)、总胆汁酸(TBA)、葡萄糖(GLU)、碱性磷酸酶(ALP)、肌酐(Cr)、直接胆红素(D-Bil)和尿酸(UA)无影响或在肝素正常抗凝浓度下(肝素浓度<20 U.ml-1血液)无影响(P>0.05);丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、γ-谷氨酰转肽酶(-γGT)、乳酸脱氢酶(LDH)、胆碱酯酶(CHE)、α-羟丁酸脱氢酶(-αHBDH)、α淀粉酶(-αAmy)、肌酸激酶(CK)、肌酸激酶同功酶-MB(CK-MB)、总胆红素(T-Bil)、前白蛋白(P-AlB)、总胆固醇(T-CHO)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-Cho)、载脂蛋白A1(ApoA1)、载脂蛋白B100(ApoB100)、糖化血清蛋白(GSP)、D-3羟丁酸(D3)和尿素(Urea)等19项生化指标均有显著性差异(P<0.05~P<0.01)。结论TP、ALB、TBA、GLU、ALP、Cr、D-Bil和UA的化学检测可使用肝素抗凝血浆,但需建立正常参考范围使结果具有可朔源性;目前条件下ALT、AST、-γGT、LDH、CHE、-αHBDH、-αAmy、CK、CK-MB、T-Bil、P-ALB、T-CHO、TG、HDL-Cho、ApoA1、ApoB100、GSP、D3和Urea运用肝素有局限性。     

子宫内膜癌495例的组织分型和预后分析

本文对495例子宫内膜癌进行了形态特点、组织起源及生物学行为的分析。病例在组织学上可分为内膜样腺癌、腺角化癌、透亮细胞癌、分泌型腺癌、鳞腺癌、浆液乳头状腺癌和粘液型腺癌等七型。根据肿瘤组织形态及生长部位,认为他们均起源于子宫内膜具有多种分化潜能的苗勒管上皮。经统计学处理,发现各型的临床分期、肌层浸润情况和肿瘤分化程度有所不同;生存率也有显著差异(p<0.01),说明组织分型是一项估计预后的病理形态指标。     

耐药蛋白在乳腺癌组织中的表达及与ER、PR状态的关系

目的研究耐药蛋白HER-2、MGMT、GST-π、P—gP、TopⅡ在乳腺癌组织中的表达、意义及与ER、PR状态的关系。方法应用S-P免疫组织化学方法检测ER、PR、HER-2、MGMT、GST-π、P—gP、TopⅡ的表达,同时取10例良性乳腺疾病及10例癌旁乳腺组织作对照。结果52例乳腺癌组织中,HER-2、MGMT、GST-π、P-gP和TopⅡ在癌组织中的表达明显高于癌旁组织;其表达率分别为36．5％、61．5％、44．2％、38．5％和51．9％。HER．2的表达与原发肿瘤直径及淋巴结转移有关（P〈0．05）,它的表达与ER、PR水平呈负相关（r=-0．67,P〈0．05）。GST-π的表达与淋巴结转移有关,与患者年龄、肿瘤大小及组织学分级无关,但与ER,PR水平呈负相关（r=-0．36,P〈0．05）;P—gP与与淋巴结转移及肿瘤组织学分级有关,差异有统计学意义（P〈0．05）;TopⅡ与患者年龄、肿瘤大小及组织学分级相关,差异有统计学意义（P〈0．05）;MGMT在不同年龄、不同肿瘤大小、组织学分级各处理组中表达差异无统计学意义,且与ER、PR状态无关。结论联合检测HER-2、MGMT、GST-π、P—gp、TopⅡ、ER和PR对于乳腺癌的治疗具有指导意义,是判断预后的重要指标。     

肝病患者手术及介入治疗后凝血纤溶指标监测对疗效的评估作用

目的探讨肝病患者手术或介入治疗后凝血及纤溶指标的变化对疗效的评估价值。方法对肝病组（100例）、肝癌组（100例）于手术或介入治疗前与后检测血浆凝血酶原时间（PT）、活化部分凝血酶原时间（AFTT）、纤维蛋白原（FIB）、抗凝血酶Ⅲ（ATⅢ）活性、蛋白C（PC）活性、蛋白S（PS）活性、纤溶酶原（PLG）活性、组织型纤溶酶原活化物（t-PA）、纤溶酶原活化剂抑制物（PAI）、α2-抗纤溶酶（α-PI）活性、纤溶酶-纤溶酶抑制物（PAP）,并与正常对照组100例比较。结果与对照组比较,肝癌组介入治疗前与后PT、APT、t-PA、PAI、PAP均明显升高（P〈0．05或〈0．01）,FIB、ATⅢ活性、PC活性、PS活性、PLG活性、α2-PI活性均明显降低（P〈0．05或〈0．01）;与介入治疗前比较,介入治疗后PT、APTT、t-PA降低,FIB、ATⅢ活性、PC活性、PS活性、PLG活性、α2-PI活性升高（P〈0．05）,而PAI-1和PAP均差异无统计学意义（P〉0．05）。与对照组比较,肝病组手术治疗前与后PT、APTT、t-PA、PAP均明显升高（P〈0．05或〈0．01）,而FIB、ATⅢ、PC活性、PS活性、PLG活性、PAI、α2-PI活性降低（P〈0．01）;与手术治疗前比较,肝病组手术治疗后PT、APTT、t-PA、PAP降低（P〈0．05或〈0．01）,FIB、ATⅢ活性、PC活性、PS活性、PLG活性、PAI、α2-PI活性升高（P〈0．05或〈0．01）。结论肝病组和肝癌组均存在抗凝活性降低及易发纤溶。手术或介入治疗后有所改善,但未完全恢复正常。     

ELEVATED SOLUBLE EPIDERMAL GROWTH FACTOR RECEPTOR LEVEL IN PITUITARY ADENOMA AND CARCINOMA

Objective To investigate effect of the soluble epidermal growth factor receptor (sEGFR/sErbB1) level in the peripheral blood in development, invasiveness, apoplexy of each type of pituitary tumor.Methods The sEGFR level was determined in peripheral serum from 190 patients with pituitary diseases by enzyme linked immunosobent assay. The sEGFR levels were measured in 10 pituitary Rathke's pouch, 18 pituitary hyperplasia, 161pituitary adenomas including 30 microadenomas, 83 large adenomas, 48 giant adenomas, 1 pituitary carcinoma, and 28 healthy controls.Results In the patients with pituitary hyperplasia, microadenoma, large adenoma, giant adenoma, and pituitary carcinoma, the sEGFR level was 188.92 32.62, 209.83 19.01,333.20 69.33, 405.85 37.38, and 617.45 fmol/mL independently. They were all significantly higher than patients with pituitary Rathke's pouch (156.78 18.24 fmol/mL, P ＜ 0.001)and healthy control group (159.11 40.50 fmol/mL, P ＜ 0.05). The sEGFR level in pituitary carcinoma was higher than pituitary adenoma. In patients with pituitary adenoma, the sEGFR level was positive correlated to the size of pituitary adenomas (r = 0.998), the significant difference was observed for the sEGFR level in each group of the patients with pituitary adenomas (P ＜ 0.001). Furthermore, in patients with pituitary ACTH-secrefing microadenomas, the serum sEGFR levels in invasiveness (295.00 77.80 fmol/mL) was higher than that in non-invasiveness (210.60 16.4 fmol/mL, P ＜ 0.05). In patients with pituitary ACTH-secreting, PRL-secreting, GH-secreting, and non-functioning large adenomas, the serum sEGFR levels in invasiveness (407.86 28.50, 399.25 30.10, 386.00 13.08, and 369.25 36.70 fmol/mL) was higher than that in non-invasiveness (335.25 63.49, 300.64 47.57, 297.00 61.93, and 269.30 25.68 fmol/mL) respectively (P ＜ 0.05). In patients with invasive pituitary PRL-secreting, GH-secreting, and non-functioning giant adenomas, the serum sEGFR levels not significantly different in between invasiveness (417.50 35.94, 409.50 69.14, and 417.50 44.13 fmol/mL) and noninvasiveness (386.00 49.64, 417.50 44.03, and 409.51 35.17 fmol/mL) (P ＞ 0.05). In patients with pituitary large adenomas, the sEGFR levels in pituitary apoplexy (377.48 39.18 fmol/mL) was higher than that in non-pituitary apoplexy(343.18 68.17 fmol/mL, P ＞ 0.05).Conclusions The increased level of peripheral serum sEGFR is concomitant with development, proliferous size of the adenomas in patients with pituitary adenomas. In addition, the elevated levels of serum sEGFR occur in pituitary apoplexy as clinical active tumors, and the non-invasive ACTH secreting adenomas. The sEGFR levels could be differentiated helpfully between pituitary adenomas and non-pituitary adenomas. These data suggest that serum sEGFR could be as a referable marker of the size and activation of proliferation in pituitary adenoma.     

血清Asprosin、Spexin水平与2型糖尿病并内脏型肥胖的相关性研究

背景　脂肪因子与体脂分布及糖脂代谢的相关性研究已成为国内外研究热点,而脂肪因子Asprosin、Spexin在2型糖尿病（T2DM）及肥胖中的研究鲜有报道。目的　探究血清Asprosin、Spexin水平与T2DM并发内脏型肥胖（VO）的相关性。方法　选取2019年1月至2020年6月于内蒙古科技大学包头医学院第一附属医院内分泌科国家标准化代谢性疾病管理中心就诊的381例T2DM患者为研究对象。依据是否发生VO将患者分为T2DM并发VO组（T2DM-VO组,n=226）、T2DM未并发VO组（T2DM-nonVO组,n=155）。本研究中VO的诊断标准为内脏脂肪面积（VFA）≥100 cm2。比较两组患者一般资料、生化指标、体脂相关指标及血清Asprosin、Spexin水平,并分析血清Asprosin、Spexin水平与各指标间的相关性。采用二元Logistic回归分析探究T2DM并发VO的影响因素。结果　T2DM-VO组患者舒张压（DBP）、身高、空腹C肽（FCP）水平、餐后2 hC肽（2 hCP）水平、三酰甘油（TG）水平、血尿酸（UA）水平、稳态模型评估胰岛素抵抗指数（HOMA-IR）、Asprosin水平高于T2DM-nonVO组,体质量、体质指数（BMI）、腰围（WC）、臀围（HC）、腰臀比（WHR）、VFA、皮下脂肪面积（SFA）、内脏脂肪面积比皮下脂肪面积（VSR）大于T2DM-nonVO组,男性所占比例、Spexin水平低于T2DM-nonVO组（P<0.05）。Asprosin与身高、体质量、BMI、WC、HC、WHR、FCP、2 hCP、TG、HOMA-IR、VFA、SFA、VSR呈正相关,与Spexin呈负相关（P<0.05）;Spexin与体质量、BMI、WC、HC、WHR、FCP、2 hCP、Cr、UA、HOMA-IR、VFA、SFA、VSR呈负相关,与HbA1c呈正相关（P<0.05）。二元Logistic回归分析结果显示,性别〔OR=2.967,95%CI（1.830,4.810）〕、BMI〔OR=1.729,95%CI（0.801,3.732）〕、WHR〔OR=0.000,95%CI（0.000,0.105）〕、SFA〔OR=0.985,95%CI（0.977,0.992）〕、Asprosin〔OR=0.539,95%CI（0.426,0.681）〕、Spexin〔OR=1.001,95%CI（1.000,1.001）〕是T2DM并发VO的影响因素（P<0.05）。结论　血清Asprosin、Spexin水平与T2DM并发VO密切相关,为治疗T2DM、预防T2DM并发症提供了新的、可能的治疗靶点。     

洛赛克与莫沙比利治疗功能性消化不良25例临床观察

目的 :为了观察洛赛克与莫沙比利治疗功能性消化不良的临床疗效。方法 :采用随机对照研究 ,4 8例功能性消化不良患者 ,随机分为两组 :A组即洛赛克与莫沙比利组 2 5例 (男性 13例 ,女性12例 ,年龄 35岁± 10岁 ) ,采用洛赛克 2 0mg ,口服 ,每天一次 ,莫沙比利 5mg ,口服 ,每天三次 ,共 2周。B组即雷尼替丁与吗叮啉组 2 3例 (男性 11例 ,女性 12例 ,年龄 34岁± 10岁 ) ,采用雷尼替丁 15 0mg ,口服 ,每天二次 ,吗叮啉 10mg ,口服 ,每天三次 ,共 2周。记录服药后两周症状改善情况。结果 :二周后 ,A组显效率为 72 .0 % ,总有效率为 88.0 % ;明显高于B组 6 0 .8% ,73.9% ;差异有显著性 (P >0 .0 5 )。且A组上腹痛、烧心、上腹胀、嗳气、早饱、厌食缓解率分别为 91.3%、90 .9%、91.7%、81.0 %、85 .0 %、86 .7 %。均明显高于B组 6 9.6 %、6 6 .6 %、78.3%、72 .7%、73.3%、71.4 %。结论 :洛赛克与莫沙比利治疗功能性消化不良有较好的疗效。     

罕见小肠囊腺瘤1例报道

SUMMARY In recent years, there have been more and more reports about cystadenoma. Cystadenoma can occur in many parts of the body, and cystadenoma in different parts may show different clinical symptoms, however, some patients with cystadenoma have no symptoms. The vast majority of cystadenomas are benign lesions, but a small number of cystadenomas can be malignant. For example, a small number of ovarian cystadenomas and pancreatic cystadenomas may be malignant. This study reported a patient with small intestinal cystadenoma diagnosed by pathology. The patient's physical examination revealed a lesion in the left upper abdomen. He had only abdominal distension and no other discomfort. His laboratory examination results were basically normal, i.e. blood routine, urine routine, stool routine, liver function, kidney function, myocardial enzyme, tumor marker, etc. The patient underwent sectional small intestine resection and the pathological sample was analyzed. The histological findings of the resected intestinal sample were consistent with cystadenoma. Computed tomography scan of the abdomen was performed 4 months after the surgery. No recurrence of the tumor was found. The patient recovered in good condition. By consulting the literature, I found very few reports of small intestinal cystadenoma before, it was very rare. This article described the clinical manifestation, diagnosis and differential diagnosis, treatment and prognosis of a case of small intestinal cystadenoma, it suggested that cystadenoma can occur in the small intestine, other than the ovary, pancreas, liver, lung, thyroid, prostate, seminal vesicle, skin, etc. The cystadenoma in small intestine is easy to be mistaken with other tumors, such as small intestine stromal tumor, small intestine adenocarcinoma, small intestine lipoma, small intestine hemangiomas, etc., and it is difficult to fully confirm through imaging examinations, such as computed tomography and magnetic resonance imaging. Laparotomy and histopathological examination are necessary before definitive diagnosis. This disease can be treated by small bowel resection at the affected region and good prognosis can be achieved.     

温度对三种蚊虫发育和繁殖的影响

目的 观察白纹伊蚊、淡色库蚊和中华按蚊等3种江苏省主要传病媒介在不同温度条件下各虫期发育与繁殖情况,了解蚊虫完成全代发育的有效温度,为制定或实时调整蚊虫防制措施提供理论依据。方法 2017年用光照培养箱饲养法,设置10、15、20、25、30、35和40 ℃等7组不同温度,分别观察实验室饲养的白纹伊蚊、淡色库蚊和中华按蚊生殖营养周期、卵期、幼虫和蛹期的发育繁殖和全发育时期情况。结果 在7组温度中,白纹伊蚊和中华按蚊在10、15和40 ℃时不能完成蚊虫全代发育,其余4组温度均能完成全代发育,其中在20、25、30和35 ℃时白纹伊蚊的平均发育时间分别为37.73、18.50、16.92和13.66 d,中华按蚊的平均发育时间分别为29.13、15.46、12.19和10.90 d;淡色库蚊除40 ℃不能完成全代发育外,其余6组温度均能完成全代发育,按照温度递增顺序平均时间分别为80.88、46.32、31.07、24.97、17.14和14.48 d。结论 一定温度范围内,蚊虫的发育周期随着温度升高而缩短,温度过高和过低均对蚊虫发育繁殖起到损害作用;温度对3种蚊虫的发育与繁殖影响有所区别。